Cc-5013-nhl-008 Magnify - Michigan Cancer Research Consortium

Từ khóa » Cc-5013-nhl-008

• Lenalidomide Plus Rituximab Followed By ...

• Rituximab Plus Lenalidomide For Patients With Relapsed ...

• Lenalidomide Lymphoma MAGNIFY (CC-5013-NHL-008)

• A Phase 3B Randomized Study Of Lenalidomide (CC-5013) Plus ...

• Cc-5013-nhl-008 (magnify) - StiL

• MAGNIFY: A Randomized, Phase 3b Trial In Patients With Relapsed ...

• Search For 2017-002290-19 - Clinical Trials Register

• Immunomodulatory Drugs Revlimid (lenalidomide) And CC-4047 ...

• A Phase III Study Of Lenalidomide Plus Rituximab Versus Placebo ...

• [PDF] Lenalidomide-accord-epar-product-information_en.pdf

• [PDF] Revlimid, INN-lenalidomide - European Medicines Agency

• Revlimid 2.5 Mg Hard Capsules - Print Friendly - (emc)

• Revlimid 5 Mg Hard Capsules - Summary Of Product Characteristics ...